RHBDF1 promotes AP-1-activated endothelial–mesenchymal transition in tumor fibrotic stroma formation
Main Authors: | Shan Gao, Li-Song Zhang, Lei Wang, Nan-Nan Xiao, Hui Long, Yi-Lun Yin, Yu-Meng Yang, Zhen Xi, Lu-Yuan Li, Zhi-Song Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00597-1 |
Similar Items
-
RHBDF1 deficiency suppresses melanoma glycolysis and enhances efficacy of immunotherapy by facilitating glucose-6-phosphate isomerase degradation via TRIM32
by: Lei Wang, et al.
Published: (2023-12-01) -
RHBDF2 gene functions are correlated to facilitated renal clear cell carcinoma progression
by: Lei Wang, et al.
Published: (2021-11-01) -
Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response
by: Hao Zeng, et al.
Published: (2022-09-01) -
TGF-β1–induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation?
by: Arnela Saljic, et al.
Published: (2022-07-01) -
Alteration of AP-endonuclease1 expression in curcumin-treated fibrotic rats
by: Ahmad R. Bassiouny, et al.
Published: (2011-10-01)